PT Merck Tbk (IDX: MERK)
Health Care · Pharmaceuticals · ID
Rp3,790.00
+2.43% today · +35.4% 1Y
PT Merck Tbk (IDX: MERK) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $94.77M and employs 358 people.
Over the last twelve months the share price has gained 35.4%, trading between 2.75K and 4.50K.
Tweenvest scores PT Merck Tbk across four factors: quality 75/100, value 83/100, growth 67/100, dividend 100/100. Its strongest factor is dividend.
MERK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $94.77M
- Revenue (TTM)
- $75.51M
- P/E
- 5.10
- EPS
- 743.66
- Dividend yield
- 7.43%
- Beta (5Y)
- 0.17
- 52-week high
- Rp4,500.00
- 52-week low
- Rp2,750.00
- Avg volume (3M)
- —
- Shares outstanding
- 448.00M
- Employees
- 358
- Next earnings
- —
About PT Merck Tbk
Operating in Indonesia, PT Merck Tbk is a pharmaceutical company focused on the production and distribution of medicinal products. Its business operations are structured into three main divisions: Biopharma, Consumer Health, and an 'Others' segment. The company provides healthcare solutions addressing a broad spectrum of therapeutic areas, including conditions related to the cardiovascular system, metabolism, oncology, endocrinology, fertility, and neurodegenerative disorders, alongside general pharmaceutical offerings. Furthermore, PT Merck Tbk is actively involved in the discovery, development, production, and commercialization of both pharmaceutical and biological prescription drugs. These medicines target specific conditions such as colorectal and head and neck cancers, multiple sclerosis, infertility, growth hormone imbalances, diabetes, and various thyroid conditions like hyperthyroidism and hypothyroidism. Beyond its core pharmaceutical activities, the company also engages in property leasing and management. Established in 1970 and headquartered in East Jakarta, Indonesia, the company was originally known as PT Merck Indonesia Tbk before adopting its current name, PT Merck Tbk, in June 2002. It operates as a subsidiary of Merck Holding GmbH.
- ISIN
- ID1000136609
- Founded
- 1970
- Listed since
- May 3, 2002
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pak Fah Yeow International LimitedSEHK: 239 | $97.30M | HK$2.45 | -0.41% |
| Grown Rogue International Inc.CNSX: GRIN | $96.43M | CA$0.55 | -9.84% |
| Renascience Inc.TSE: 4889 | $96.35M | ¥1,103.00 | -9.44% |
| Kyongbo Pharmaceutical Co., LtdKOSE: A214390 | $96.21M | ₩5,420.00 | +0.56% |
| KUKJEON Co.,LtdKOSDAQ: A307750 | $94.60M | ₩2,360.00 | +4.89% |
| AlzeCure Pharma AB (publ)OM: ALZCUR | $94.26M | Skr6.74 | -1.75% |
| Unité de Fabrication des Médicaments S.ABVMT: UMED | $94.01M | DT8.80 | +0.57% |
| Sunhawk Vision Biotech, Inc.TPEX: 7759 | $93.96M | NT$42.55 | +1.79% |
Figures last refreshed Oct 4, 2026.